Effects of oxysterols on the blood-brain barrier: Implications for Alzheimer's disease

被引:52
|
作者
Gosselet, Fabien
Saint-Pol, Julien
Fenart, Laurence
机构
[1] Univ Lille Nord France, Lille, France
[2] UArtois, LBHE, EA 2465, Lens, France
[3] IMPRT IFR114, Lille, France
关键词
Oxysterols; Blood-brain barrier; ABCA1; ABCB1; Alzheimer's disease; LXR; CAPILLARY ENDOTHELIAL-CELLS; AMYLOID-BETA-PEPTIDE; BODY CHOLESTEROL METABOLISM; TO-BASOLATERAL TRANSPORT; TRANSGENIC MOUSE MODEL; P-GLYCOPROTEIN; IN-VITRO; APOLIPOPROTEIN-E; A-BETA; NEURODEGENERATIVE DISEASES;
D O I
10.1016/j.bbrc.2013.11.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Altered brain cholesterol homeostasis plays a key role in neurodegenerative diseases such as Alzheimer's disease (AD). For a long time, the blood-brain barrier (BBB) was basically considered as a barrier isolating the brain from circulating cholesterol, however, several lines of evidence now suggest that the BBB strictly regulates the exchanges of sterol between the brain and the peripheral circulation. Oxysterols, synthesized by neurons or by peripheral cells, cross the BBB easily and modulate the expression of several enzymes, receptors and transporters which are involved not only in cholesterol metabolism but also in other brain functions. This review article deals with the way oxysterols impact BBB cells. These perspectives open new routes for designing certain therapeutical approaches that target the BBB so that the onset and/or progression of brain diseases such as AD may be modulated. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:687 / 691
页数:5
相关论文
共 50 条
  • [41] Editorial: Imaging of the blood-brain barrier in Alzheimer's disease and related disorders
    Uchida, Yuto
    Shao, Xingfeng
    Montagne, Axel
    Matsukawa, Noriyuki
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [42] Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier
    Takeuchi, Lily E.
    V. Kalia, Lorraine
    Simmons, Craig A.
    NEUROBIOLOGY OF DISEASE, 2025, 208
  • [43] Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier"
    Simpkins, James W.
    ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 433 - 434
  • [44] Blood-brain barrier dysfunction and Alzheimer's disease: associations, pathogenic mechanisms, and therapeutic potential
    Chen, Yanting
    He, Yanfang
    Han, Jinling
    Wei, Wenyan
    Chen, Feng
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [45] Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier
    Wong, Ka Hong
    Riaz, Muhammad Kashif
    Xie, Yuning
    Zhang, Xue
    Liu, Qiang
    Chen, Huoji
    Bian, Zhaoxiang
    Chen, Xiaoyu
    Lu, Aiping
    Yang, Zhijun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (02)
  • [46] Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer's disease patients
    Suzuki, Masayoshi
    Tezuka, Kenta
    Handa, Takumi
    Sato, Risa
    Takeuchi, Hina
    Takao, Masaki
    Tano, Mitsutoshi
    Uchida, Yasuo
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (11) : 2134 - 2150
  • [47] Role of ischmic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain
    Pluta, Ryszard
    CURRENT NEUROVASCULAR RESEARCH, 2007, 4 (02) : 121 - 129
  • [48] Brain Ischemia in Alzheimer's Disease May Partly Counteract the Disruption of the Blood-Brain Barrier
    Bateman, Grant A.
    Bateman, Alexander R.
    BRAIN SCIENCES, 2025, 15 (03)
  • [49] Imaging blood-brain barrier disruption in neuroinflammation and Alzheimer's disease
    Lee, Rae-Ling
    Funk, Kristen E.
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [50] Endothelial Dysfunctions in Blood-Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies
    Yue, Qian
    Leng, Xinyue
    Xie, Ningqing
    Zhang, Zaijun
    Yang, Deguang
    Hoi, Maggie Pui Man
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (11)